Pembrolizumab Concurrent with Radiotherapy Does Not Improve the Tumour Control and Survival in Locally Advanced Squamous Cell Carcinoma of Head and Neck Unfit for Cisplatin
PembroRad shows less toxicity from standard of care regimen in unfit patients